Rockefeller Capital Management L.P. - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 15 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q2 2021$23,000
-39.5%
3,9650.0%0.00%
Q1 2021$38,000
+15.2%
3,965
+75.4%
0.00%
Q4 2020$33,0002,2600.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 396,425$5,927,0000.29%
Gradient Capital Advisors, LLC 21,718$325,0000.18%
Hillsdale Investment Management Inc. 15,200$232,0000.02%
Orion Portfolio Solutions, LLC 15,821$237,0000.01%
IFP Advisors, Inc 1,960$30,0000.00%
BANK OF AMERICA CORP /DE/ 300$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 7$00.00%
MORGAN STANLEY 2,100$31,0000.00%
BANK OF MONTREAL /CAN/ 5,900$98,0000.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders